A new article by Dr. Steve Ommen and Dr. Chris Semsarian entitled “Hypertrophic cardiomyopathy: a practical approach to guideline directed management” was published today in The Lancet. This blog entry has been updated to link to that article.
The highly anticipated 2020 American Heart Association/American College of Cardiology Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy have been released.
This document, drafted with reference to published HCM literature, and with input from a committee of HCM experts with broad expertise, updates the prior version published in 2011. It contains clinical practice guidelines for the broad spectrum of issues which may confront medical professionals as they approach the diagnosis and treatment of patients and families affected by hypertrophic cardiomyopathy.
View original post 462 more words
4 thoughts on “2020 AHA/ACC HCM Diagnosis & Treatment Guidelines Released – Updated With New Links”